HT KIT
Alternative Names: HT-KIT mRNA Frame Shifting TherapeuticLatest Information Update: 17 Nov 2023
At a glance
- Originator North Carolina State University
- Developer Hoth Therapeutics
- Class Antineoplastics; Antisense oligonucleotides; Morpholines; Skin disorder therapies
- Mechanism of Action Proto-oncogene protein c-kit expression inhibitors; RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Anaphylaxis; Leukaemia; Mastocytosis